Advanced Accelerator Application SA(ADR) Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
-	-

2017	WDH/Novartis will US-Unternehmen Advanced Accelerator Applications übernehmen	DP
2017	Novartis will US-Unternehmen Advanced Accelerator Applications übernehmen	DP

WDH/Novartis will US-Unternehmen Advanced Accelerator Applications übernehmen	30.10.17	DP
Novartis will US-Unternehmen Advanced Accelerator Applications übernehmen	30.10.17	DP

Advanced Accelerator Applications signs exclusive option and license agreement with FUJIFILM Toyama Chemical to develop and commercialize radiolabeled FF-10158 for oncology indications	03.12.18
Advanced Accelerator Applications Signs Exclusive License Agreement with Cancer Targeted Technology to Develop CTT1057, an F-18 Labeled PSMA Ligand for Diagnostic Applications in Prostate Cancer	12.02.18
Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender Offer	01.02.18
Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors	26.01.18
Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender Offer	22.01.18

Manager	Titel	Alter	Seit
Caio Kugelmas DFI	Director of Finance/CFO	-	-
Sidonie Roswitha Golombowski-Daffner CHM	Chairman	-	01.10.19
Ute Simon CTO	Chief Tech/Sci/R&D Officer	-	01.04.20

Aufsichtsräte	Titel	Alter	Seit
Frédéric Collet BRD	Director/Board Member	-	01.01.18
Jessica Toepfer BRD	Director/Board Member	-	01.01.18
Sidonie Roswitha Golombowski-Daffner CHM	Chairman	-	01.10.19

Sektor

	% 1. Jan.	Kap.
MERCK KGAA	+3,37 %	69,85 Mrd.
KYOWA KIRIN CO. LTD.	+11,77 %	8,98 Mrd.
SK BIOPHARMACEUTICALS CO., LTD.	-12,75 %	4,89 Mrd.
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+42,38 %	4,44 Mrd.
YUHAN CORPORATION	+5,23 %	3,95 Mrd.
INDIVIOR PLC	+21,69 %	2,49 Mrd.
BETTA PHARMACEUTICALS CO., LTD.	-19,05 %	2,4 Mrd.
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-28,72 %	2,28 Mrd.
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+11,13 %	1,96 Mrd.